EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long-Term Humoral Immune Dynamics in Healthcare Workers with Hybrid and Vaccine-Induced Immunity: The VaCoMRI Study

Mehmet Tekinsoy iD, Osman Merdan iD, Rabia Rusen iD, Catharina Christa, Katharina Müller, Alina Priller iD, Hrvoje Mijocevic, Hedwig Roggendorf, Otto Zelger, Kathrin Tinnefeld, Samuel D Jeske iD, Duluur Vasilev und 5 weitere

Viruses · 2026

DOI: 10.3390/v18091040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2026. Verfasst von Mehmet Tekinsoy und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Virology, School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany. Hauptthemen laut MEDLINE: Health Personnel, Antibodies, Viral, SARS-CoV-2, COVID-19. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Center for Infection Research, Munich, German Center for Infection Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The VaCoMRI study tracked a cohort of healthcare workers from 2020 through June 2024 to characterize the long-term sustainability of hybrid and vaccine-induced SARS-CoV-2 immunity.

Methods

An initial anti-nucleocapsid (N) IgG screening of 4554 health-care workers in early 2020 identified participants who had been infected during the first wave. Anti-N-positive and anti-N-negative individuals then received BNT162b2 through the institutional vaccination program, yielding groups with hybrid and vaccine-induced immunity. Both groups were monitored regularly for nearly four years for breakthrough infections (BTI). Serum collected regularly after vaccination and after BTI was analyzed for anti-N, quantitative anti-spike (anti-S) IgG, and surrogate viral neutralizing antibody (sVNT) titers.

Results

Over a median follow-up of 1180 days, 142 healthcare workers contributed longitudinal samples; 66.2% experienced one BTI and 14.1% a second. In initially seronegative individuals, anti-N titers decreased 2.3-fold between 3 and 6 months after the first BTI, with seropositivity dropping from 82% to 40.4% (median time to seronegativity: 179 days). Prior anti-N seropositivity was associated with 4.5-fold higher anti-N IgG levels after BTI, with elevated levels persisting through 9 months. In both groups, the third vaccine dose significantly enhanced anti-S antibody persistence after 9 months compared to the second dose. In infection-naïve individuals, anti-S IgG titers remained 4.2-fold and sVNT titers 7.2-fold higher. Hybrid immunity was similarly durable: two vaccine doses after prior anti-N seropositivity yielded anti-S IgG and sVNT levels comparable to three-dose vaccination.

Conclusions

This study demonstrates a rapid waning of anti-N IgG that severely limits its reliability for retrospective serosurveillance of SARS-CoV-2 exposure in occupational settings. The combination of vaccination and infection induced robust and durable spike-directed antibody responses. However, these were determined using assays based on the ancestral spike protein. This may limit the prediction of protection from SARS-CoV-2 variants, which usually cause BTIs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Health PersonnelAntibodies, ViralSARS-CoV-2COVID-19Immunity, HumoralHumansMaleFemaleBNT162 VaccineAdultBreakthrough InfectionsImmunoglobulin GAntibodies, NeutralizingMiddle AgedVaccinationSpike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

BNT162b2SARS-CoV-2anti-nucleocapsid IgGanti-spike IgGantibody kineticsbreakthrough infectionhealthcare workerssurrogate virus neutralization

Substanzen

Antibodies, ViralBNT162 VaccineImmunoglobulin GAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Autor:innen und Institutionen

  • Institute of Virology, School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany.
  • Institute of Molecular Immunology, University Hospital Rechts der Isar, Technical University of Munich, 81675 Munich, Germany.
  • Occupational Medicine, University Hospital Rechts der Isar, Technical University of Munich, 81675 Munich, Germany.
  • Department for Internal Medicine II, University Hospital Rechts der Isar, Technical University of Munich, 81675 Munich, Germany.
  • German Center for Infection Research (DZIF), 81675 Munich, Germany.
  • Helmholtz Center Munich, 81675 Munich, Germany.

ORCID-Profile: Mehmet Tekinsoy, Osman Merdan, Rabia Rusen, Alina Priller, Samuel D Jeske, Dieter Hoffmann, Percy A Knolle, Ulrike Protzer

Förderung

  • German Center for Infection Research, Munich
  • German Center for Infection Research

Zitieren

APA

Tekinsoy, M., Merdan, O., Rusen, R., Christa, C., Müller, K., Priller, A., Mijocevic, H., Roggendorf, H., Zelger, O., Tinnefeld, K., Jeske, S. D., Vasilev, D., Yazici, S., Erber, J., Hoffmann, D., Knolle, P. A., & Protzer, U. (2026). Long-Term Humoral Immune Dynamics in Healthcare Workers with Hybrid and Vaccine-Induced Immunity: The VaCoMRI Study. Viruses. https://doi.org/10.3390/v18091040

Vancouver

Tekinsoy M, Merdan O, Rusen R, Christa C, Müller K, Priller A, et al. Long-Term Humoral Immune Dynamics in Healthcare Workers with Hybrid and Vaccine-Induced Immunity: The VaCoMRI Study. Viruses. 2026. doi:10.3390/v18091040

BibTeX
@article{Tekinsoy2026,
  author = {Tekinsoy, Mehmet and Merdan, Osman and Rusen, Rabia and Christa, Catharina and Müller, Katharina and Priller, Alina and Mijocevic, Hrvoje and Roggendorf, Hedwig and Zelger, Otto and Tinnefeld, Kathrin and Jeske, Samuel D and Vasilev, Duluur and Yazici, Sarah and Erber, Johanna and Hoffmann, Dieter and Knolle, Percy A and Protzer, Ulrike},
  title = {Long-Term Humoral Immune Dynamics in Healthcare Workers with Hybrid and Vaccine-Induced Immunity: The VaCoMRI Study},
  journal = {Viruses},
  year = {2026},
  doi = {10.3390/v18091040}
}
Kostenlos starten →